![](/img/cover-not-exists.png)
Safety, Pharmacokinetics, Immunogenicity, and Biodistribution of 186 Re-Labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab( in Patients with Early-Stage Breast Cancer
Koppe, Manuel, Schaijk, Frank van, Roos, Jan, Leeuwen, Paul van, Heider, Karl-Heinz, Kuthan, Hartmut, Bleichrodt, RobertVolume:
19
Language:
english
Journal:
Cancer Biotherapy & Radiopharmaceuticals
DOI:
10.1089/cbr.2004.19.720
Date:
December, 2004
File:
PDF, 145 KB
english, 2004